Open AccessA prospective, randomized, double-blind, comparative clinical study of efficacy and safety of a biosimilar adalimumab with innovator product in patients with active rheumatoid arthritis on a stable dose of methotrexate
Author(s) -
Prasad Apsangikar,
Sunil Chaudhry,
Manoj Kumar Naik,
Shashank Deoghare,
Jamila Joseph
Publication year - 2018
Publication title -
indian journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 11
eISSN - 0973-3701
pISSN - 0973-3698
DOI - 10.4103/0973-3698.233164
Subject(s) - biosimilar , rheumatoid arthritis , adalimumab , medicine , innovator , methotrexate , randomized controlled trial , pharmacology , computer science , intellectual property , operating system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom